Seeking Alpha

Biopharmaceutical company Ziopharm Oncology (ZIOP -5.5%) says it plans to sell an undisclosed...

Biopharmaceutical company Ziopharm Oncology (ZIOP -5.5%) says it plans to sell an undisclosed number of shares of common stock to fund the development of its drug candidates, as well as for general corporate and working capital purposes.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)